Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of T cells with bispecific antibodies and Fc fusions

Modulation of T cells with bispecific antibodies and Fc fusions

US Patent 11091548 · Granted Aug 17, 2021

Estimated economic value: $17,882,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Anti-human C5 antibodies2025
CTLA4-Ig immunoadhesins2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Heterodimeric proteins2025
Heterodimeric proteins2025
Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and2025
Heterodimeric antibodies that bind CD3 and CLDN62025